D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDR
1426
DELISTED
Cedar Realty Trust, Inc
CDR
| $2.48M | ﹤0.01% |
110,665
+45,404
| +70% | +$1.02M |
|
1427
First Busey Corp
BUSE
$2.19B
| $2.48M | ﹤0.01% |
101,592
+13,712
| +16% | +$335K |
|
1428
Digi International
DGII
$1.33B
| $2.48M | ﹤0.01% |
195,536
-28,913
| -13% | -$366K |
|
1429
Ternium
TX
$6.8B
| $2.48M | ﹤0.01% |
90,969
-220,739
| -71% | -$6.01M |
|
1430
Customers Bancorp
CUBI
$2.32B
| $2.47M | ﹤0.01% |
135,118
-44,323
| -25% | -$812K |
|
|
NEX
1431
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $2.46M | ﹤0.01% |
225,491
+65,623
| +41% | +$715K |
|
1432
Allied Gaming & Entertainment
AGAE
$56.3M
| $2.45M | ﹤0.01% |
240,000
| – | – |
|
1433
Lam Research
LRCX
$148B
| $2.45M | ﹤0.01% |
136,570
-322,860
| -70% | -$5.78M |
|
1434
Univest Financial
UVSP
$886M
| $2.45M | ﹤0.01% |
99,983
+54,123
| +118% | +$1.32M |
|
1435
Targa Resources
TRGP
$35.8B
| $2.44M | ﹤0.01% |
58,786
+33,223
| +130% | +$1.38M |
|
1436
Foster
FSTR
$291M
| $2.44M | ﹤0.01% |
129,401
-3,134
| -2% | -$59K |
|
1437
NVR
NVR
$23.3B
| $2.44M | ﹤0.01% |
880
+50
| +6% | +$138K |
|
1438
Lennar Class B
LEN.B
$34B
| $2.43M | ﹤0.01% |
65,399
-10,189
| -13% | -$379K |
|
1439
Caesarstone
CSTE
$48.4M
| $2.42M | ﹤0.01% |
155,147
+74,294
| +92% | +$1.16M |
|
|
ACOR
1440
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $2.42M | ﹤0.01% |
1,516
-565
| -27% | -$901K |
|
1441
Schneider National
SNDR
$4.18B
| $2.4M | ﹤0.01% |
114,039
+51,924
| +84% | +$1.09M |
|
1442
Hanmi Financial
HAFC
$748M
| $2.39M | ﹤0.01% |
112,327
-11,206
| -9% | -$238K |
|
1443
Gentex
GNTX
$6.25B
| $2.38M | ﹤0.01% |
114,949
-44,010
| -28% | -$910K |
|
1444
Prestige Consumer Healthcare
PBH
$3.11B
| $2.37M | ﹤0.01% |
79,348
-30,948
| -28% | -$926K |
|
|
ACR
1445
ACRES Commercial Realty
ACR
$154M
| $2.37M | ﹤0.01% |
74,278
-800
| -1% | -$25.5K |
|
1446
SandRidge Energy
SD
$420M
| $2.36M | ﹤0.01% |
293,649
+182,392
| +164% | +$1.46M |
|
|
SEMG
1447
DELISTED
SEMGROUP CORPORATION
SEMG
| $2.35M | ﹤0.01% |
+159,523
| New | +$2.35M |
|
1448
Thor Industries
THO
$5.55B
| $2.35M | ﹤0.01% |
37,675
-15,140
| -29% | -$944K |
|
1449
Biglari Holdings Class B
BH
$943M
| $2.35M | ﹤0.01% |
16,617
-400
| -2% | -$56.5K |
|
1450
Bank OZK
OZK
$5.88B
| $2.35M | ﹤0.01% |
81,049
+71,655
| +763% | +$2.08M |
|